Email Updates

You are here

Home

California Collaborative Treatment Group Consortium/ALERT (Active Linkage, Engagement and Retention to Reduce HIV)

Status
Ongoing
Phase
Demo Project
Principal Investigator(s)
Sheldon Morris & David Moore
Objective

Plans to enroll 400 eligible high-risk MSM, for two years who will receive daily TDF/FTC-based PrEP, into a randomized study that evaluates whether a text messaging–based adherence intervention can improve adherence to the PrEP medication.

Prevention Option(s)
PrEP
Study Design
Randomized
Open label
Official Code
NCT01761643
Trial Sponsors
California Collaborative Treatment Group; University of California, San Diego; UCLA; University of Southern California; City of Long Beach Department of Health and Human Services; California HIV/AIDS Research Program; Gilead Sciences
Product Developers
California HIV/AIDS Research Program of the University of California, San Diego County HIV, STD, and Hepatitis Branch and the Long Beach Health and Human Services Agency
January 2013
July 2016
Enrollment
400
18
Years
Population
Men
MSM
Sites

City of Long Beach Department of Health and Human Services

Long Beach, California
United States of America

University Southern California

Los Angeles, California
United States of America

University of California, San Diego

San Diego, California
United States of America

Harbor-UCLA Medical Center

Torrance, California
United States of America